AHA News: Cancer Survivor Feared Recurrence, But This Time It Was His Heart

Monday, April 6, 2020 (American Heart Association News) -- Doug Cobb popped a couple antacid pills to calm the heartburn he'd been experiencing on and off for weeks. The 60-year-old considered he might have a stomach problem, but waved it off,...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news

Related Links:

Most people know about the damaging effects that binge drinking can bring to someone’s life. Loss of enjoyment of life, losing family relationships, financial and career struggles, homelessness, and legal consequences are just the tip of the iceberg. However, it can be more difficult to realize the long-term effect of binge drinking on the body, because you cannot always see it. Frequent binge drinking poses many dangerous health risks, and many of them can lead to death. Facts on Long-Term Effect of Binge Drinking on the Body For men, binge drinking is defined as consuming five or more drinks within about two hour...
Source: Cliffside Malibu - Category: Addiction Authors: Tags: Alcohol Alcohol Rehab Information Alcoholism alcohol abuse alcohol dependence alcohol treatment alcohol treatment center binge binge drinking Source Type: blogs
Peter Denson, 66, a retired coach engineer from Kent, suffered 20 years of seemingly harmless hiccups, burping and heartburn. He was shocked to be diagnosed with oesophageal cancer.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
CVS has halted sales of popular heartburn treatment Zantac and its generic store brand after warnings by U.S. health regulators. It’s the latest precautionary move by retailers and manufacturers after the U.S. Food and Drug Administration recently warned consumers about a potentially dangerous contaminant in prescription and over-the-counter versions of Zantac. In its announcement this weekend, CVS said customers who bought Zantac products can return them for a refund. The retailer will continue to sell other heartburn medications. What’s the issue? In September, the FDA said it detected low levels of a probabl...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized medicine onetime Source Type: news
If you or a family member take ranitidine (Zantac) to relieve heartburn, you may have heard that the FDA has found a probable human carcinogen (a substance that could cause cancer) in it. The story is unfolding quickly and many details remain murky. Here is what we know so far and what you should do. What do we know so far? On September 13, 2019, the FDA announced that preliminary tests found low levels of N-nitrosodimethylamine (NDMA) in ranitidine, a heartburn medication used by millions of Americans. This week, the drug companies Novartis (through its generic division, Sandoz) and Apotex announced that they were recalli...
Source: Harvard Health Blog - Category: Consumer Health News Authors: Tags: Digestive Disorders Drugs and Supplements Health Source Type: blogs
If you or a family member take ranitidine (Zantac) to relieve heartburn, you may have heard that the FDA has found a probable human carcinogen (a substance that could cause cancer) in it. The story is unfolding quickly and many details remain murky. Here is what we know so far and what you should do. What do we know so far? On September 13, 2019, the FDA announced that preliminary tests found low levels of N-nitrosodimethylamine (NDMA) in ranitidine, a heartburn medication used by millions of Americans. This week, the drug companies Novartis (through its generic division, Sandoz) and Apotex announced that they were recalli...
Source: Harvard Health Blog - Category: Consumer Health News Authors: Tags: Digestive Disorders Drugs and Supplements Health Source Type: blogs
(WASHINGTON) — U.S. health officials said Friday they are investigating low levels of a potentially dangerous contaminant in the popular heartburn medication Zantac and related generic drugs. For now, though, the Food and Drug Administration said patients can continue taking their medications. The agency said it has detected a “probable” cancer-causing chemical in the medications, which are sold as both prescription and over-the-counter treatments to treat stomach acid and ulcers. FDA officials said the amount of the impurity barely exceeds levels found in common foods. But the same chemical has been link...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized Drugs health onetime Source Type: news
(CNN) — The US Food and Drug Administration said on Friday that it has learned that some ranitidine — acid-reducing and heartburn medicines, including those known by the brand name Zantac — contain low levels of an impurity that could cause cancer. The nitrosamine impurity known as N-nitrosodimethylamine or NDMA has been classified as a probable human carcinogen based on lab tests, and this isn’t the first time that it has been detected in a common medication. Since last year, the FDA has been investigating NDMA and other impurities in blood pressure and heart failure medicines known as angiotensin ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Health News CNN FDA Heartburn Source Type: news
THURSDAY, June 6, 2019 -- People who use common heartburn drugs for months to years may face heightened risks of dying from heart disease, kidney failure or stomach cancer, a new study suggests. The study included more than 200,000 U.S. veterans....
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
New research finds a link between proton pump inhibitors and heightened risk of death from heart disease, kidney disease, and stomach cancer.
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Acid Reflux / GERD Source Type: news
(Washington University in St. Louis) A study by researchers at Washington University School of Medicine in St. Louis and Veterans Affairs St. Louis Health Care System has linked long-term use of such popular heartburn drugs -- called proton pump inhibitors (PPIs) -- to fatal cases of cardiovascular disease, chronic kidney disease and upper gastrointestinal cancer. More than 15 million Americans have prescriptions for PPIs.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
More News: Cancer | Cancer & Oncology | Cardiology | Gastric (Stomach) Cancer | General Medicine | Heart | Heartburn